神经復健设备市场规模、份额和成长分析（按类型、应用、最终用户和地区）- 产业预测 2025-2032

神经復健设备市场规模预计在 2023 年达到 16 亿美元，并从 2024 年的 17.3 亿美元成长到 2032 年的 33.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.4%。

由于对中风、多发性硬化症和帕金森氏症等神经系统疾病的有效復健解决方案的需求不断增加，神经復健设备市场正在蓬勃发展。这种增长是由于人口老化和生活方式的改变导致这些疾病的盛行率不断增加。神经復健设备提供标靶治疗，以提高患者的独立性和功能能力。然而，这个市场面临的挑战包括需要持续研究以提高设备的有效性和易用性、高成本以及有限的报销选择。然而，人工智慧和机器人等技术的进步为改善神经復健结果提供了重大机会。总体而言，在技术创新和不断增长的患者群体的推动下，美国神经復健设备市场预计未来几年将保持强劲成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究分析

神经復健设备市场规模（按类型和复合年增长率）（2025-2032）

• 市场概况
• 神经机器人设备
• 非侵入式刺激器
• 脑机介面

神经復健设备市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 中风
• 帕金森氏症
• 多发性硬化症
• 脊髓损伤
• 创伤性脑损伤
• 脑性麻痹
• 其他的

神经復健设备市场规模（按最终用户和复合年增长率划分）（2025-2032）

• 市场概况
• 復健中心
• 医院
• 诊所

神经復健设备市场规模（依地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic（US）
• Abbott Laboratories（US）
• Boston Scientific Corporation（US）
• Stryker Corporation（US）
• Smith & Nephew plc（UK）
• Ekso Bionics Holdings, Inc.（US）
• Bioxtreme Robotics Rehabilitation（Italy）
• ReWalk Robotics Ltd.（Israel）
• Neurostyle Pte. Ltd.（Singapore）
• Kinova Robotics（Canada）
• Neuro Rehab VR（US）
• Tyromotion GmbH（Austria）
• Neofect（South Korea）
• Enraf-Nonius（Netherlands）
• Hobbs Rehabilitation（UK）
• Motek Medical BV（Netherlands）

结论和建议

Neurorehabilitation Devices Market size was valued at USD 1.6 billion in 2023 and is poised to grow from USD 1.73 billion in 2024 to USD 3.31 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The neurorehabilitation devices market is expanding rapidly to meet the rising demand for effective rehabilitation solutions for neurological disorders, including stroke, multiple sclerosis, and Parkinson's disease. Contributing to this growth is the increasing prevalence of these conditions, driven by an aging population and shifting lifestyles. Neurorehabilitation devices offer targeted therapies that enhance patient independence and functional abilities. However, the market faces challenges such as the need for ongoing research to improve device effectiveness and usability, along with high costs and limited reimbursement options. Nonetheless, advancements in technologies like artificial intelligence and robotics present significant opportunities for enhanced neurorehabilitation outcomes. Overall, the U.S. neurorehabilitation devices market is projected to sustain robust growth in the coming years, driven by innovations and an expanding patient base.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurorehabilitation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurorehabilitation Devices Market Segments Analysis

Global Neurorehabilitation Devices Market is segmented by Type, Application, End User and region. Based on Type, the market is segmented into Neuro-Robotic Devices, Non-Invasive Stimulators and Brain-Computer Interfaces. Based on Application, the market is segmented into Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy and Others. Based on End User, the market is segmented into Rehabilitation Centers, Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurorehabilitation Devices Market

A key driver of the neurorehabilitation devices market is the ongoing technological advancements that have emerged in recent years. Significant progress in fields such as robotics, virtual reality, wearable sensors, and brain-computer interfaces has led to the creation of more advanced and effective neurorehabilitation devices. These innovations facilitate targeted therapies and personalized rehabilitation solutions tailored to individual patient needs. For instance, devices such as the EksoGT exoskeleton developed by Ekso Bionics and the ReWalk system from ReWalk Robotics are specifically designed to aid individuals with mobility challenges, enhancing their ability to walk and improving overall motor skills. These advancements are revolutionizing the approach to neurorehabilitation.

Restraints in the Neurorehabilitation Devices Market

A significant challenge facing the neurorehabilitation devices market is the elevated cost linked to these technologies. The use of advanced innovations like robotics and brain-computer interfaces drives up the price of these devices. Furthermore, the need for specialized knowledge to properly utilize such equipment adds to the overall expense of treatment. This financial burden can restrict access to neurorehabilitation devices, especially in areas where healthcare resources are scarce or insurance coverage is insufficient. Consequently, the economic barrier poses a considerable limitation, hindering the widespread adoption and availability of these crucial rehabilitation solutions.

Market Trends of the Neurorehabilitation Devices Market

The neurorehabilitation devices market is increasingly trending towards tele-rehabilitation solutions, driven by their ability to provide effective remote therapy options. This shift has accelerated in the wake of the COVID-19 pandemic, as traditional in-person rehabilitation faced interruptions, prompting both patients and clinicians to embrace digital alternatives. Tele-rehabilitation enhances accessibility and convenience, enabling patients to engage in rehabilitation sessions from the comfort of their homes while facilitating continuous monitoring by healthcare professionals. This trend not only promotes personalized care but also expands market opportunities for innovative telehealth technologies, positioning tele-rehabilitation as a cornerstone for the future of neurorehabilitation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Neurorehabilitation Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Neuro-Robotic Devices
• Non-Invasive Stimulators
• Brain-Computer Interfaces

Global Neurorehabilitation Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Brain Stroke
• Parkinson's Disease
• Multiple Sclerosis
• Spinal Cord Injury
• Traumatic Brain Injury
• Cerebral Palsy
• Others

Global Neurorehabilitation Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Rehabilitation Centers
• Hospitals
• Clinics

Global Neurorehabilitation Devices Market Size & CAGR (2025-2032)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ekso Bionics Holdings, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioxtreme Robotics Rehabilitation (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReWalk Robotics Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurostyle Pte. Ltd. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kinova Robotics (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuro Rehab VR (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tyromotion GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neofect (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enraf-Nonius (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hobbs Rehabilitation (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Motek Medical B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations